Tan Kevin 4
4 · Solid Biosciences Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Solid Biosciences (SLDB) CFO Kevin Tan Sells Shares
What Happened
Kevin Tan, CFO & Treasurer of Solid Biosciences (SLDB), had 10,625 restricted stock units (RSUs) vest and convert into 10,625 shares on Feb 13, 2026. Following the vesting, he sold 5,404 shares in an open-market sell-to-cover on Feb 18, 2026 at a weighted average price of $5.82, generating proceeds of $31,469. The remaining 5,221 shares (10,625 − 5,404) were retained. The sale was executed under a pre-existing sell-to-cover instruction and was therefore non‑discretionary.
Key Details
- Transaction dates: RSU conversion/vest recorded 2026-02-13; open-market sale 2026-02-18.
- Sale details: 5,404 shares sold at a weighted average price of $5.82 for total proceeds of $31,469; prices in the sale ranged from $5.23 to $6.14 (per filing).
- RSU detail: The RSUs were granted 2025-02-13 and vest 25% annually over four years (footnote). Each RSU equals one share upon settlement.
- Net change: +5,221 shares retained after the sell-to-cover.
- Footnotes: The sale was a sell-to-cover to satisfy tax withholding under a durable automatic sales instruction letter (adopted Aug 15, 2024); the sell was non‑discretionary.
- Timeliness: The Form 4 was filed on 2026-02-18. The Feb 13 vesting/conversion was reported five days later (filed Feb 18), which is later than the typical two-business-day reporting window for Form 4 (so the vesting/conversion appears reported late by one business day).
Context
These entries reflect routine RSU vesting and a sell-to-cover for taxes rather than a discretionary decision to sell shares. For retail investors, such tax-withholding sales are common and do not necessarily indicate insider sentiment about the company. Purchases by insiders tend to be more informative than routine sell-to-cover transactions.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-13+10,625→ 104,826 total - Sale
Common Stock
[F2][F3]2026-02-18$5.82/sh−5,404$31,469→ 99,422 total - Exercise/Conversion
Restricted Stock Units
[F1][F4]2026-02-13−10,625→ 21,250 total→ Common Stock (10,625 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Tan on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Tan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.
- [F4]The restricted stock units were granted on February 13, 2025 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.